← SynDRA
BALICATIB
SynDRA canonical compound SYN0006020 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CTSK |
|---|
| Mechanism of action | Cathepsin inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Cathepsin inhibitor
- CTSK INHIBITOR
- Cathepsin K inhibitor
Cross-references
Synonyms
- AAE-581
- AAE581
- N-[1-(cyanomethylcarbamoyl)cyclohexyl]-4-(4-propylpiperazin-1-yl)benzamide
- AAE 581
- E00MVC7O57
- balicatibum
- RefChem:116378
- DTXCID20111480
- Balicatib [INN]
- MFCD19443790
- UNII-E00MVC7O57
- Balicatib?
- Balicatib (aae-581)
- BALICATIB [WHO-DD]
- GTPL7861
- orb1307327
- SCHEMBL1587772
- BDBM19855
- EX-A362
- LLCRBOWRJOUJAE-UHFFFAOYSA-N
- C23H33N5O2
- GLXC-06343
- HMS3740C15
- EPA81319
- AKOS025149083
- basic piperazine-containing compound, 10
- NCGC00371151-01
- NCGC00371151-06
- NCGC00371151-09
- AC-35832
- AS-56087
- DA-35184
- HY-15100
- SY242132
- NS00069660
- S0194
- T1850
- F863462
Look up BALICATIB in the interactive SynDRA portal →